Cutting Edge Information

Authorized generics' branded pharmaceuticals gain share of generics market

Published in Pharma Law Weekly, September 27th, 2005

Generic drug manufacturers have become particularly adept at choosing battles they know they can win.

Evidence abounds - they win more than 70 percent of patent infringement cases settled in the courts, according to a report, "Combating Generics: Pharmaceutical Brand Defense," from pharmaceutical business intelligence firm Cutting Edge Information.

They are also winning in cases settled outside the courts. Authorized generics is a strategy pursued by branded pharmaceuticals whereby a brand manufacturer gives permission to one generic manufacturer - usually as part of a patent infringement lawsuit settlement - to distribute a generic copy of a drug...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2005-09-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry